<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In addition to chromosomal translocation, the MYC gene in the N-terminal coding region showed clustered point mutations in Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A recent study showed that these point mutations inactivated the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> activity of MYC and contributed to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> transformation </plain></SENT>
<SENT sid="2" pm="."><plain>To see whether the point mutations of MYC are involved in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> besides Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, we analyzed the N-terminal cluster region of the mutations in 507 cancers from gastric, colorectal, breast and <z:mp ids='MP_0008714'>lung carcinomas</z:mp>, and <z:hpo ids='HP_0002488'>acute leukemias</z:hpo>, by polymerase chain reaction-based single-strand conformation polymorphism assay </plain></SENT>
<SENT sid="3" pm="."><plain>However, there was no <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> of the MYC gene in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The data suggest that the point mutation of the MYC gene in the N-terminal domain may be very rare and may not contribute to the development of common human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> besides Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>